Cytosorbents (CTSO) FCF Margin (2011 - 2026)
Cytosorbents (CTSO) posted FCF Margin of 13.23% for Q1 2026, up 75.23% on a QoQ basis from 53.42% in Q4 2025, and up 2651.0% year-over-year from 0.48% in Q1 2025.
Cytosorbents (CTSO) FCF Margin (2011 - 2026) Analysis & Trends
Cytosorbents' FCF Margin history runs 16 years deep, the most recent figure standing at 13.23% for Q1 2026.
- Quarterly FCF Margin rose 2651.0% year-over-year to 13.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27.54% (up 933.0% YoY) and the FY2025 annual result came in at 33.84%, up 672.0% from the prior year.
- FCF Margin was 13.23% for Q1 2026 at Cytosorbents, up from 53.42% in the prior quarter.
- Across five years, FCF Margin topped out at 1.85% in Q4 2022 and bottomed at 152.61% in Q3 2022.
- A 5-year average of 52.89% and a median of 53.42% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 12273 bps — and 2023, when it surged 9352 bps.
- Cytosorbents' FCF Margin stood at 1.85% in 2022, then tumbled by 4433 bps to 80.13% in 2023, then jumped by 71 bps to 23.32% in 2024, then sank by 129 bps to 53.42% in 2025, then jumped by 75 bps to 13.23% in 2026.
- Business Quant data shows CTSO's FCF Margin at 13.23% in Q1 2026, 53.42% in Q4 2025, and 27.35% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -13.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.23% |
| Dec 31, 2025 | -53.42% |
| Sep 30, 2025 | -27.35% |
| Jun 30, 2025 | -16.08% |
| Mar 31, 2025 | -39.74% |
| Dec 31, 2024 | -23.32% |
| Sep 30, 2024 | -30.36% |
| Jun 30, 2024 | -54.42% |
| Mar 31, 2024 | -54.23% |
| Dec 31, 2023 | -80.13% |
| Sep 30, 2023 | -59.09% |
| Jun 30, 2023 | -73.60% |
| Mar 31, 2023 | -32.89% |
| Dec 31, 2022 | 1.85% |
| Sep 30, 2022 | -152.61% |
| Jun 30, 2022 | -88.98% |
| Mar 31, 2022 | -101.59% |
| Dec 31, 2021 | -84.70% |
| Sep 30, 2021 | -29.88% |
| Jun 30, 2021 | -23.49% |